Novak Djokovic holds 80 per cent stake of Danish biotech developing COVID-19 treatment: CEO

Tennis star Novak Djokovic has an 80 per cent stake of Danish biotech firm QuantBioRes, which aims to develop a medical treatment to counter COVID-19, said the company’s chief executive officer. He added that the investment was made in June 2020 but refused to say how much it was.

QuantBioRes has around 11 researchers who work in Denmark, Australia and Slovenia, according to Loncarevic, who stressed they were working on a treatment and not a vaccine.

He also added that the company is developing a peptide, which inhibits the coronavirus from infecting the human cell and expects to launch clinical trials in Britain this summer.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

mersin escort